Controlled Substance Monitoring Hybrid Drug Profile, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine

Casandra

Casandra Test Code MC72050Version 1 (DRAFT)

Performing Lab

Lab Mayo Clinic LabLab Test ID CSMHU

Controlled Substance Monitoring Hybrid Drug Profile, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine

Clinical Use

Use

This test is useful for detecting drug use involving stimulants, barbiturates, benzodiazepines, cocaine, opioids, and tetrahydrocannabinol. It is a comprehensive monitoring tool for controlled substance use, assisting in the management of patients in pain management, substance use treatment, or compliance monitoring programs.

Special Instructions

Not provided.

Limitations

Confirmation testing is not automatically reflexed if the immunoassay screen is positive. It must be requested or ordered separately, indicating that a positive initial screen does not confirm presence without further testing.

Test Details

New York Approved

Methodology

Mass Spectrometry (LC-MS/MS)

Biomarkers

5 components

Adulterants Survey, U • Clinical Chemistry AnalyzerLimited Drug Panel, 3, IA, U • LC-MS/MSTargeted Opioid Screen, U • LC-MS/MS HRAMTargeted Benzodiazepine Screen, U • LC-MS/MS HRAM+1 more